MENU
EMR
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

EMR stock forecast, quote, news & analysis

Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands... Show more

EMR
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Jul 19, 2026

Emerson Electric (EMR) Stock Analysis: JPMorgan Upgrade Puts Focus on $8.2 Billion Backlog Conversion

Key Takeaways

  • Emerson Electric shares traded near $139.50 in mid-July 2026, about 7.4% below levels seen 30 days earlier, underperforming the broader industrials sector.
  • JPMorgan upgraded EMR to Overweight with a $157 price target on July 17, citing accelerating backlog conversion from long-cycle power, LNG, semiconductor, and aerospace projects.
  • The company reported Q2 FY2026 earnings of $1.54 per share, beating estimates, and reaffirmed full-year guidance of $6.45–$6.55 per share.
  • Analyst consensus remains a Moderate Buy, with a mean price target of approximately $162.64, implying notable upside from current levels.
  • Emerson's backlog reached $8.2 billion, up 9% year-over-year, supported by a project funnel of $11.2 billion and continued strength in high-growth verticals.

Current Market Snapshot

Emerson Electric Co. (EMR) has traded under moderate pressure in recent weeks, with the stock retreating from roughly $150.66 in mid-June to approximately $139.54 by July 17, 2026 — a decline of about 7.4% over the 30-day window. The pullback has been driven partly by broader industrials rotation, lingering geopolitical uncertainty in the Middle East, and short-term revenue headwinds from software contract renewals and softness in China. The 50-day moving average sits near $140.35 while the 200-day moving average hovers around $141.81, indicating the stock is trading below both short-term and long-term trend indicators. Despite the slide, institutional ownership remains robust at 74.3%, and several major Wall Street firms have recently issued or reaffirmed constructive ratings.

Emerson Electric (EMR) Business Overview and Competitive Position

Emerson Electric is a global automation and industrial technology leader headquartered in St. Louis, Missouri. The company engineers and delivers process automation systems, measurement and analytical instrumentation, control valves and actuators, control software, and comprehensive aftermarket services to customers across industrial, commercial, and consumer markets. Following its portfolio transformation — including the sale of a majority stake in its Climate Technologies business (now Copeland) to Blackstone — Emerson has refocused as a pure-play automation powerhouse. Its operations span the Americas, Asia/Middle East/Africa, and Europe, supporting essential industries such as energy, life sciences, power generation, LNG, semiconductors, and aerospace and defense. With a market capitalization near $78 billion and a 55-year track record of consecutive dividend increases, Emerson is widely regarded as a bellwether for global industrial capital spending.

Recent Developments Driving EMR

Several developments have shaped investor sentiment around Emerson Electric over the past month. On July 17, JPMorgan upgraded EMR from Neutral to Overweight with a $157 price target, arguing that large, long-cycle projects are now transitioning from order backlog into recognized revenue. The firm highlighted Emerson's 9% backlog growth year-over-year and pointed to improving conditions in the process industries, with rising rig counts and upward revisions to refinery capital expenditure forecasts. JPMorgan also noted potential upside from Middle East infrastructure rebuilding, which is not fully reflected in current guidance.

In a separate move, Bernstein initiated coverage with an Outperform rating and a $175 price target on June 10, emphasizing Emerson's positioning in LNG, power, pharmaceuticals, semiconductors, aerospace and defense, and electric vehicles. DA Davidson launched coverage with a Neutral rating and a $145 target, while Barclays raised its target to $144 with an Equal Weight rating.

On the product front, Emerson announced new software solutions — Crude Schedule Optimization and Multi-Blend Optimization — within its Aspen Unified Scheduling platform on July 16, designed to help refineries improve margins and respond faster to market volatility. The company has also deepened its partnership with SiMa.ai to embed advanced artificial intelligence capabilities into industrial PCs, enabling real-time data analytics without cloud dependency. Emerson's Q3 FY2026 earnings are scheduled for release on August 4, with management expecting earnings per share between $1.65 and $1.70.

Trending AI Robots

For investors seeking data-driven trading strategies, Tickeron's Trending AI Robots page offers a curated view of top-performing AI-powered trading bots. Tickeron operates hundreds of AI trading bots that actively trade thousands of tickers across diverse strategies, timeframes, and performance metrics, but only the most relevant and consistently high-performing bots are featured in this dedicated section. Each bot employs distinct algorithmic approaches — ranging from swing trading to trend-following — allowing users to explore different methodologies suited to varying market conditions. Browsing the Trending AI Robots page can help traders identify strategies that align with their investment style while leveraging real-time AI analysis to support decision-making.

2026 Outlook and What Investors Should Watch

Looking ahead, Emerson's investment case hinges on several key drivers. The conversion of its $8.2 billion backlog into revenue during the second half of fiscal 2026 remains the central catalyst, particularly as long-cycle projects in power generation, LNG infrastructure, and aerospace defense continue ramping. The company's software division — with annual contract value growing at a 10%-plus pace — represents a high-margin growth engine, further enhanced by AI integration and digital transformation demand across industrial end markets.

Investors should monitor the upcoming Q3 FY2026 earnings report on August 4 for updates on sales growth, margin trajectory, and any adjustments to full-year guidance. Geopolitical developments in the Middle East remain a wildcard; Emerson has modeled a roughly $100 million disruption but also sees a comparable repair-and-restart opportunity over the next six quarters. Additional factors include the trajectory of Chinese industrial demand, ongoing strength in North American energy markets, and the pace of capital deployment for share repurchases — with Emerson targeting approximately $2.2 billion in total shareholder returns during fiscal 2026. Analyst consensus points to fiscal 2027 EPS of approximately $7.05, suggesting mid-to-high single-digit earnings growth if execution remains on track.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

A.I.Advisor
a Summary for EMR with price predictions
Jul 31, 2026

Momentum Indicator for EMR turns positive, indicating new upward trend

EMR saw its Momentum Indicator move above the 0 level on July 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for EMR just turned positive on July 22, 2026. Looking at past instances where EMR's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

EMR moved above its 50-day moving average on July 23, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EMR crossed bullishly above the 50-day moving average on July 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in of 335 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for EMR moved out of overbought territory on July 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EMR broke above its upper Bollinger Band on July 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EMR entered a downward trend on July 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.134) is normal, around the industry mean (5.857). P/E Ratio (34.681) is within average values for comparable stocks, (59.887). Projected Growth (PEG Ratio) (2.089) is also within normal values, averaging (2.036). Dividend Yield (0.015) settles around the average of (0.019) among similar stocks. P/S Ratio (4.617) is also within normal values, averaging (137.659).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Dividends

EMR paid dividends on June 10, 2026

Emerson Electric Co EMR Stock Dividends
А dividend of $0.56 per share was paid with a record date of June 10, 2026, and an ex-dividend date of May 15, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Illinois Tool Works (NYSE:ITW), Ingersoll Rand (NYSE:IR), Generac Holdings (NYSE:GNRC).

Industry description

The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.

Market Cap

The average market capitalization across the Industrial Machinery Industry is 16.24B. The market cap for tickers in the group ranges from 1.55K to 263.75B. GEV holds the highest valuation in this group at 263.75B. The lowest valued company is XEBEF at 1.55K.

High and low price notable news

The average weekly price growth across all stocks in the Industrial Machinery Industry was -1%. For the same Industry, the average monthly price growth was -11%, and the average quarterly price growth was -6%. GFUZ experienced the highest price growth at 50%, while LBGJ experienced the biggest fall at -39%.

Volume

The average weekly volume growth across all stocks in the Industrial Machinery Industry was 59%. For the same stocks of the Industry, the average monthly volume growth was -90% and the average quarterly volume growth was 24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 56
Price Growth Rating: 59
SMR Rating: 72
Profit Risk Rating: 73
Seasonality Score: -34 (-100 ... +100)
View a ticker or compare two or three
EMR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of process controls systems, valves and analytical instruments

Industry IndustrialMachinery

Profile
Details
Industry
Electrical Products
Address
8000 West Florissant Avenue
Phone
+1 314 553-2000
Employees
67000
Web
https://www.emerson.com
Emerson Electric (EMR) Stock Analysis: JPMorgan Upgrade Puts Focus on $8.2 Billion Backlog Conversion